Meningococcal conjugate vaccine groups ACYW135 (Tianjin CanSino Biotechnology)

ACYW135็พค่„‘่†œ็‚Ž็ƒ่Œ็ป“ๅˆ็–ซ่‹—๏ผˆๅบทๅธŒ่ฏบ๏ผ‰

Report date: 2024/03/29 14:52:10

Base Information

Drug NameMeningococcal conjugate vaccine groups ACYW135 (Tianjin CanSino Biotechnology)
Drug Alias Name่„‘่†œ็‚Ž็ƒ่Œ็ป“ๅˆ็–ซ่‹—็ป„ACYW135group A/C/Y/W135 meningococcal conjugate vaccineACYW135็พค่„‘่†œ็‚Ž็ƒ่Œๅคš็ณ–็ป“ๅˆ็–ซ่‹—๏ผˆCRM197่ฝฝไฝ“๏ผ‰ๅ››ไปท่„‘่†œ็‚Ž็ƒ่Œ็ป“ๅˆ็–ซ่‹—ๅ››ไปทๆต่„‘็ป“ๅˆ็–ซ่‹—(ๅบทๅธŒ่ฏบ) +[7]ย 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccine +[4]ย 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisEncephalomyelitisMeningitis, Meningococcal
Global Approved IndicationsMeningitis
Approved Indications in ChinaMeningitis
Original Approved Country/TerritoryMainland China
Original Approved Date2021/12/27
Country/TerritoryIndonesiaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMeningitisEncephalomyelitisMeningitis, Meningococcal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A